Other interesting data were the lower gene levels for some of the components of the acetylcholine receptor (CHRNB1, CHRNA1 and CHRNG) that may result in a significant reduction of the amplitude of the transmission signal, as has already been demonstrated for myasthenia gravis patients. The gene discussed is CHRNB1; the disease is myasthenia gravis.